Europe's medicines watchdog said Wednesday it has started to review an adapted version of Pfizer/BioNTech's anti-Covid jab in order to better protect against specific variants of the virus, including Omicron.
A third dose of COVID-19 vaccine can provide up to 88 per cent protection against hospitalisation from infection by the Omicron variant of coronavirus, according to early results from studies conducted in the UK.
More than 74 lakh (74,59,819) COVID-19 vaccine doses had been administered till 7:00 pm on Thursday, noted the Ministry of Health and Family Welfare in an official statement.